Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Evaluation of Enterotoxigenic Bacteroides Fragilis Correlation With the Expression of Cellular Signaling Pathway Genes in Iranian Patients With Colorectal Cancer Publisher



Dadgarzankbar L1 ; Shariati A2, 3 ; Bostanghadiri N1 ; Elahi Z1 ; Mirkalantari S1 ; Razavi S1 ; Kamali F4 ; Darbansarokhalil D1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  2. 2. Molecular and Medicine Research Center, Khomein University of Medical Sciences, Khomein, Iran
  3. 3. Student Research Committee, Khomein University of Medical Sciences, Khomein, Iran
  4. 4. Iran National Tumor Bank, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran

Source: Infectious Agents and Cancer Published:2023


Abstract

Background: Colorectal cancer (CRC) is one of the most common cancers all over the world, and dysbiosis in the gut microbiota may play a role in colorectal carcinogenesis. Bacteroides fragilis can lead to tumorigenesis by changing signaling pathways, including the WNT/β-catenin pathway. Therefore, in the present study, we investigated the correlation between the enterotoxigenic B. fragilis amount and the expression of signaling pathway genes involved in CRC. Materials and methods: B. fragilis was determined in 30 tumors and adjacent healthy tissues by the qPCR method. Next, the relationship between enterotoxigenic B. fragilis and the expression of signaling pathway genes, including CCND1, TP53, BCL2, BAX, WNT, TCF, AXIN, APC, and CTNNB1 was investigated. Additionally, possible correlations between clinicopathological features of the tumor samples and the abundance of B. fragilis were analyzed. Results: The results showed that B. fragilis was detected in 100% of tumor samples and 86% of healthy tissues. Additionally, enterotoxigenic B. fragilis colonized 47% of all samples, and bft-1 toxin was the most frequently found isotype among the samples. The analysis showed that the high level of B. fragilis has a significant relationship with the high expression of AXIN, CTNNB1, and BCL2 genes. On the other hand, our results did not show any possible correlation between this bacterium and the clinicopathological features of the tumor sample. Conclusion: B. fragilis had a higher abundance in the tumor samples than in healthy tissues, and this bacterium may lead to CRC by making changes in cellular signaling pathways and genes. Therefore, to better understand the physiological effects of B. fragilis on the inflammatory response and CRC, future research should focus on dissecting the molecular mechanisms by which this bacterium regulates cellular signaling pathways. © 2023, BioMed Central Ltd., part of Springer Nature.
Related Docs
View other Related Docs
1. Alterations of the Gut Microbiome and Metabolome Following: A Opportunity for Early Detection of Colorectal Cancer, Current Cancer Therapy Reviews (2025)
2. Association Between Colorectal Cancer and Fusobacterium Nucleatum and Bacteroides Fragilis Bacteria in Iranian Patients: A Preliminary Study, Infectious Agents and Cancer (2021)
3. Enterotoxigenic Bacteroides Fragilis: A Possible Etiological Candidate for Bacterially-Induced Colorectal Precancerous and Cancerous Lesions, Frontiers in Cellular and Infection Microbiology (2020)
4. Association of Lactobacillus, Firmicutes, Bifidobacterium, Clostridium, and Enterococcus With Colorectal Cancer in Iranian Patients, Heliyon (2023)
5. Role of Gut Microbiota in the Pathogenesis of Colorectal Cancer; a Review Article, Gastroenterology and Hepatology from Bed to Bench (2018)
6. Bacterial Biomarkers: New Aspects of Colorectal Tumors Diagnosis: Reality or Fantasy, European Journal of Cancer Prevention (2023)
7. Toxigenic and Non-Toxigenic Patterns I, Ii and Iii and Biofilm-Forming Ability in Bacteroides Fragilis Strains Isolated From Patients Diagnosed With Colorectal Cancer, Gut Pathogens (2020)
8. Antibiotic Resistance Pattern of Bacteroides Fragilis Isolated From Clinical and Colorectal Specimens, Annals of Clinical Microbiology and Antimicrobials (2021)
Experts (# of related papers)
View all Related Experts
Mohammad Mehdi Feizabadi (4)
Mohammad Sadegh Fazeli (3)
Other Related Docs
9. Exploring the Interplay Between Fusobacterium Nucleatum With the Expression of Microrna, and Inflammatory Mediators in Colorectal Cancer, Frontiers in Microbiology (2023)
10. Assessment of Anti-Cancer Effects of Koenimbine on Colon Cancer Cells, Human Antibodies (2020)
11. Significant Difference in Gut Microbiota Bifidobacterium Species But Not Lactobacillus Species in Colorectal Cancer Patients in Comparison With Healthy Volunteers Using Quantitative Real-Time Pcr, PLoS ONE (2024)
12. 16S Rrna Sequencing Analysis of the Oral and Fecal Microbiota in Colorectal Cancer Positives Versus Colorectal Cancer Negatives in Iranian Population, Gut Pathogens (2024)
13. Alterations in the Gut Microbiota and Their Metabolites in Human Intestinal Epithelial Cells of Patients With Colorectal Cancer, Molecular Biology Reports (2024)